Introducing Sudden Science

3
5538
Sudden Science

For Immediate Release:

For more information, please contact
Michael Diamond, Co-founder of The Infection Prevention Strategy at
[email protected]  or visit us at
www.InfectionControl.tips (IC.tips) and www.Infectiontips.org

Introducing: Sudden Science

‘Validate your product, service, invention or idea faster’

Hamilton – September 17, 2016: The Infection Prevention Strategy is pleased to announce our Sudden Science program for the Pan-Access Journal InfectionControl.tips.

We believe that technology and ideas must be vetted and introduced faster.  Too many great ideas run out of money before they are “proven” and “accepted.”  We can’t afford to wait years for scientific publications before we adopt promising methods and technologies that show improvement.

The IC.tips Sudden Science program is geared to start-ups, individuals, companies, researchers and everyone everywhere to help move science forward faster and to make a difference in global health sooner rather than later.

The most remarkable part of what we do is that we publish and operate for FREE.  There are no fees for publishing with us and no fees to access our resources or journal.  We provide accessible scientific services that are affordable and unmatched anywhere in the world, by connecting unrelated sponsors to studies ensuring no conflict of interest.

Why wait years for your paper to be peer reviewed and published? We produce top-tier results utilizing the SAME protocols as the other journals, but do so within weeks or months, not years.

APPLY NOW: Sudden Science Application

We have redefined Open Access as Pan-Access:
Free to Publish. Free to Access. Accessible Scientific Services.

Our offering includes:

Publish on IC.tips
1-2 weeks
Peer Review
4-6 weeks
Product Review
2-3 weeks
Study (Efficacy, Evaluation, Sterility)
7 wks – 1yr+
Pilot Implementation
1-2 months
Protocol/Methodology Development
2-3 weeks
Abstracts
1-2 weeks
IRB
1-2 weeks

 

APPLY NOW: Sudden Science Application

Join. Contribute. Make A Difference. 

About InfectionControl.tips –

The Infection Prevention Strategy is a Not-For-Profit organization that operates both globally and locally. We perform scientific studies and evaluations. We promote and communicate results and experiences through our Pan-Access publication, InfectionControl.tips  – www.IC.tips

We are Pan-Access: Free to Publish. Free to Access. Accessible Scientific Services.

https://infectioncontrol.tips/

http://infectiontips.org/

Join. Contribute. Make A Difference.

Last Updated: February 9, 2017

SHARE
Previous articleFood Recalls: North America August 21 – August 27, 2016
Next articleFood Recalls: North America August 28 – September 3, 2016
Michael Diamond
Co-founder of The Infection Prevention Strategy (TIPS) Michael Diamond is the co-founder of The Infection Prevention Strategy (TIPS), a non-profit organization that recently announced $1,000,000 in Scientific Impact in its first 24 months of operation. Michael is devoted to advancing information and science to address the myriad issues relating to infection prevention and global health. Mr. Diamond is driven by the firm belief that we should not have to wait years for promising technology, ideas and processes to be implemented and accepted. Michael has created a model of information sharing that makes the process of vetting new technologies, implementing successful programs and inspiring innovation, more efficient, more accessible, more global and more collaborative. Michael’s most notable achievement to date is the TIPS online journal, www.IC.tips, a Pan-Access, worldwide collective that extends globally and touches locally. Michael leads teams around the world to develop trials and pilot studies to aid in the discovery of successful research-to-market technological advancements. His global team includes engagers and implementers. Currently represented in 38 countries, and well-established as the world’s largest engagement network, the TIPS motto is: Join. Contribute. Make A Difference.

3 COMMENTS

LEAVE A REPLY